What non‑controlled medication can be given to a patient before an MRI to promote relaxation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Non-Controlled Anxiolytic for Pre-MRI Relaxation

Hydroxyzine is the best non-controlled medication option for pre-MRI anxiolysis in adults, given as 25-100 mg orally 1-2 hours before the procedure. 1

Primary Recommendation

Hydroxyzine stands out as the optimal choice because:

  • It is explicitly approved for anxiolytic use in both Europe and the United States 1
  • It is a sedative antihistamine with few contraindications 1
  • It is available in both tablet and syrup formulations, making administration flexible 1
  • It is not a controlled substance, avoiding regulatory barriers and documentation requirements

Alternative Non-Controlled Options

Diphenhydramine (Benadryl)

  • Dose: 50 mg orally or intramuscularly 1 hour before MRI 2
  • Originally used in pretreatment protocols for radiocontrast media reactions, but has sedative/anxiolytic properties
  • Widely available and familiar to most practitioners
  • Caveat: Less specific anxiolytic effect compared to hydroxyzine; primarily an antihistamine with sedating side effects

H2-Antihistamines

  • Can be added to H1-antihistamines for enhanced effect 2
  • Examples include famotidine or ranitidine
  • Caveat: Weaker anxiolytic effect when used alone; best as adjunct therapy

Non-Pharmacological Approaches Should Be First-Line

Before reaching for medication, the evidence strongly supports:

  • Video preparation showing the MRI environment and procedure - significantly reduces anxiety, especially in first-time patients (p=0.025) 3
  • Audiovisual distraction systems during the scan - relieved high-state anxiety in 63.6-81.8% of anxious patients versus only 42.9% with standard approach 4
  • Clear communication and orientation about what to expect 5
  • Adequate lighting and soothing ambient environment 1

What NOT to Use (Controlled Substances)

While highly effective, these require DEA registration and controlled substance protocols:

  • Benzodiazepines (midazolam, lorazepam, diazepam) - controlled Schedule IV 6, 5, 7
  • Dexmedetomidine - requires IV access and continuous monitoring 8
  • Pentobarbital - controlled Schedule II/III depending on formulation 9

Clinical Implementation Algorithm

  1. Screen for anxiety level using validated tools (STAI questionnaire if available) 3, 4

  2. For mild-moderate anxiety:

    • Provide video preparation showing MRI procedure 3
    • Offer audiovisual entertainment during scan 4
    • Consider hydroxyzine 25-50 mg PO 1-2 hours pre-procedure 1
  3. For moderate-high anxiety:

    • Hydroxyzine 50-100 mg PO 1-2 hours before MRI 1
    • Combine with non-pharmacological interventions
    • Ensure patient has escort home (sedating effects)
  4. For severe anxiety/claustrophobia unresponsive to above:

    • May require controlled substances (benzodiazepines)
    • Consider anesthesiology consultation for deeper sedation protocols 1

Important Caveats

  • Hydroxyzine causes sedation - patients need transportation home and should not drive for 4-6 hours
  • Anticholinergic effects - use caution in elderly patients (confusion, urinary retention, dry mouth)
  • Contraindications: Early pregnancy (first trimester), narrow-angle glaucoma, severe hepatic impairment
  • Onset time matters - give 1-2 hours before procedure for peak effect
  • Document informed consent regarding sedation effects and driving restrictions

Why This Matters for MRI Specifically

MRI examinations have unique anxiety triggers:

  • Confined space (claustrophobia affects 14.3% of adult patients) 10
  • Loud gradient noise
  • Length of examination (often 30-60 minutes)
  • Need to remain completely still

The failure rate from anxiety-related issues can be reduced by 63% with appropriate anxiolytic premedication 11, making this intervention clinically significant for completing diagnostic studies and avoiding repeat examinations.

References

Guideline

eanm procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine.

European Journal of Nuclear Medicine and Molecular Imaging, 2023

Guideline

the diagnosis and management of anaphylaxis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2005

Research

Anxiety relaxation during MRI with a patient-friendly audiovisual system.

Radiography (London, England : 1995), 2022

Research

Adult claustrophobia, anxiety and sedation in MRI.

Magnetic resonance imaging, 1997

Research

Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2000

Related Questions

What medication can be administered to help a patient remain still and relaxed during magnetic resonance imaging (MRI)?
In a 13‑day‑old infant presenting with fever and poor feeding, what interventions should emergency medical services (EMS) perform?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What are the differential diagnoses for aggressive behavior in a 10-year-old child?
In a 12‑month‑old male with normal growth and exam, which absent developmental milestone (e.g., pointing to a body part, responding to name, stacking two blocks, using a cup, or walking independently) would be most concerning and warrant further investigation?
What are the likely diagnoses for a 27‑year‑old male with ADHD, recurrent depressive and anxiety symptoms, possible bipolar spectrum features, binge‑eating disorder, and trauma‑related PTSD after childhood sexual abuse and recent knee surgery?
How should I manage a patient with neurosarcoidosis (brain, spinal cord, optic neuritis) and lung, liver, and kidney involvement who is already receiving infliximab, regarding infliximab dosing, steroid taper, steroid‑sparing agents, and monitoring?
What questions should be asked to assess a patient's functional capacity in metabolic equivalents (METs)?
Can a patient switch from Lyrica (pregabalin) to gabapentin without tapering?
Can an adult with an acute flexural eczema flare safely use a urea‑containing cream or Vanicream as a moisturizer in addition to triamcinolone 0.1% cream?
What is the appropriate treatment and follow‑up plan for a 3.4 cm complex ovarian cyst that appears hemorrhagic with low‑level Doppler flow?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.